J&J booster slashes Omicron hospitalizations: study

A booster dose of Johnson & Johnson Inc's single-dose COVID-19 vaccine was 84% effective at preventing hospitalization in South African healthcare workers who became infected as the Omicron variant spread, researchers said on Thursday. Olivia Chan reports.

from news.com.au — Australia’s leading news site https://ift.tt/3eEBpxE
https://ift.tt/eA8V8J
December 31, 2021 at 12:40AM
A booster dose of Johnson & Johnson Inc's single-dose COVID-19 vaccine was 84% effective at preventing hospitalization in South African healthcare workers who became infected as the Omicron variant spread, researchers said on Thursday. Olivia Chan reports.